glp 1 drugs india Can GLP-1 generics fix India's obesity epidemic, which goes beyond body size? GLP-1 DRUGS IN INDIA: REGULATION,

Schilrreff P, Alexiev U

Nutrition 26, 250254

Tirzepatide causes a modest heart rate increase (2-4 bpm average)

The results were significant: At 48 weeks, participants receiving the 12 mg dose achieved a mean weight reduction of 24.2% (approximately 58 pounds or 26.2 kg) 100% of participants on the 8 mg or 12 mg doses lost at least 5% of their body weight More than 90% of participants on the 12 mg dose lost at least 10% of their body weight Nearly half of participants on the highest dose lost 25% or more of their body weight The study also showed improvements in cardiometabolic markers including blood pressure, triglycerides, LDL cholesterol, and fasting glucose

The Challenge of Recall and Exposure Accuracy One often-overlooked limitation in studies on medication use during pregnancy is the accuracy of exposure data